1Christer Betsholtz , Linda Karlsson, Per Lindahl. Developmental roles of platelet drived growth factors. BioEssays, 2001, 23 (2): 494
2George D. Platelet - derived growth factor receptors: a therapeutic target in solid tumors. Semin Oncol, 2001, 28 ( 1 ): 27
3Klinghoffer RA, Mueting - Nelsen PF, Faerman A et al. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol cell, 2001, 7 (2): 343
4Yoshinori Okamura , Akira Myoumoto, Noboru Manabe, et al. Protein tyrosine kinase expression in the porcine ovary. Molecular Human Rep. 2001, 7 (8): 723
5Taylor CC. Platelet - derived growth factor activates porcine thecal cell phosphatidylinositol - 3 - kinase - Akt/PKB and ras extracellular signal - regulated kinase - 1/2 kinase signaling pathways via the platelet - derived growth factor - beta receptor. Endocrinology, 2000, 141 (4):1545
6Schmandt BE , Broaddus R, Lu KH et al. Expression of c - ABL, c KIT, and platelet - derived growth factor receptor - beta in ovarian serous carcinoma and nomal ovarian surface epithelium. Cancer, 2003,15; 98 (4): 758
7Matei D, Chang DD, Jeng MH. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet derived growth factor receptor alpha and Akt inactivation. Clin Cancer Res, 2004, 10 (2): 681
8Apte SM, Bucana CD, Killion JJ et al. Expression of platelet - derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecol Oncol, 2004,93 (1): 78
9Larochelle WJ, Jeffers M, Corvalan JR et al. Platelet - derived growth factor D: tumorigenicity in mice and dysregnlated expression in human cancer. Cancer Res, 2002, 62 (9): 2468
10Apte SM, Fan D, Killion JJ et al. Targeting the platelet - derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin Cancer Res, 2004, 10 (3): 897
